Blood cancer patient Maureen King has flown out to China for costly experimental cancer treatment her family hopes might extend her life, and at the same t ...

Farber Cancer Institute have developed a blood test that could transform the diagnosis and monitoring of multiple myeloma (MM) and its precursor conditions. The new method, known as SWIFT-seq, ...

Researchers have developed a blood-based diagnostic method for multiple myeloma and its precursor conditions. The method ...

Researchers at Dana-Farber Cancer Institute have developed a blood test that could transform the diagnosis and monitoring of ...

Cancer survival has doubled in the past half a century, but around 167,000 people still die of the disease in the UK every ...

According to Research by SNS Insider, U.S. Multiple Myeloma Market is projected to reach USD 13.91 Billion by 2032, as novel drug classes, immunotherapies, and diagnostic advances reshape treatment ...

Cilta-cel’s mechanism of action allows it to penetrate challenging areas of multiple myeloma, providing deep and durable ...

Genmab (GMAB) traded higher on Thursday after the Danish biotech, with its H1 2025 results, announced that its bispecific ...